Univariate analysis specified that gender (p = 0.008), bone metastases (p < 0.001), liver metastases (p < 0.001), and LAT (p = 0.005) were associated with OS in metastatic ESCC patients receiving chemotherapy. This evidence concerns the gene LAT and esophageal squamous cell carcinoma.